Antiallergic effect of two variants of Artemisia princeps Pampanini

Natural Product Sciences

Volumn 12, Issue 2, 2006, Pages 67-73

  Shin, Yong Wook ^a   Bae, Eun Ah ^a   Lee, Bomi ^a   Min, Sungwon ^a   Lee, Jin Hee ^a   Baek, Nam In ^a   Ryu, Su No ^b   Chung, Hae Gon ^c   Kim, Nam Jae ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Korea National Open University   (South Korea)

^c GangHwa Agricultural R and D Center   (South Korea)

Author keywords

Acute dermatitis; Antiallergic effect; Artemisia princeps Pampanini; Passive cutaneous anaphylaxis reaction; Sajabalssuk; Sajuarissuk

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALCOHOL; ANTIALLERGIC AGENT; ARTEMISIA PRINCEPS EXTRACT; BETA N ACETYLHEXOSAMINIDASE; FREE RADICAL; IMMUNOGLOBULIN E; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTEMISIA; ARTICLE; ASTHMA; BEHAVIOR; BLOOD VESSEL PERMEABILITY; CELL CULTURE; CONTROLLED STUDY; DERMATITIS; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME RELEASE; MOUSE; NONHUMAN; RHINITIS; SKIN ALLERGY; SUPERCRITICAL FLUID EXTRACTION; WRITHING TEST;

EID: 33745886268     PISSN: 12263907     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Austin, L.M., Ozawa, M., Kikuchi, T., Walters, I.B., and Krueger, J.G., The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-r, interleukin-2, and tumor necrosis factor-a, defining Tc1 (cytotoxic T lymphocyte) and Th1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J. Invest. Dermatol, 113, 752-759 (1999).
2. Bielory, L., Complementary and alternative interventions in asthma, allergy, and immunology. Ann. Allergy Asthma Immunol., 93 (2 Suppl 1), S45-54 (2004).
3. Choo, M.K., Park, E.K., Han, M.J., and Kim, D.H., Antiallergic activity of ginseng and its ginsenoside. Planta Med., 69, 518-22 (2003).
4. Cox, J.S.G., Disodium cromglycate (FPL-670)('Intar"): A specific inhibitor of reaginic antibody-antigen mechanism. Nature, 216, 1326-1329 (1967).
5. Friedman, E.S., LaNatra, N., and Stiller, M.J., NSAIDs in dermatologic therapy: review and preview. J. Cutan. Med. Surg., 6, 449-59 (2002).
6. Fujii, Y., Takeuchi, H., Tanaka, K., Sakuma, S., Ohkubo, Y., and Mutoh, S., Effects of FK-506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats. Eur. J. Pharmacol., 456, 115-121 (2002).
7. Kim, S.U., Lee, S.D., Kim, W.B., Lee, M.G., and Kim N.D., Determination of a new antiulcer agent, eupatilin, in rat plasma, bile, urine, liver homogenate by high performance liquid chromatography. Res. Commun. Mol. Path. Pharmacol., 97, 165-170 (1997).
8. Kim, H.M., Lee, J.H., Won, J.H., Park, E.J., Chae, H.J., Kim, H.R., Kim, C.H., Baek, S.H., Inhibitory effect on immunoglobulin E production in vivo and in vitro by Siegesbeckia glabrescens. Phytother Res., 15, 572-576 (2001).
9. Nicoloff, B.J., The cytokine network in psoriasis. Arch. Dermatol., 127, 871-884 (1991).
10. Ovigne, J.M., Baker, B.S., Brown, D.W., Powles, A.V., and Fry, L., Epidermal CD8+ T cells in chronic plaque psoriasis are Tc1 cells producing heterogeneous levels of interferon-gamma. Exp. Dermatol., 10, 168-174 (2001).
11. Plaut, M., Pierce, J.H., Whatson, C., Hanley-Hyde, J., Nordan, R.P., and Paul, W.E., Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionopore. Nature, 339, 64-67 (1989).
12. Reynolds, N.J., Voorhees, J.J., and Fisher G.H., Cyclsoporin A inhibits 12-O-tetradecanoyl-phorbol-13-acetate-induced cutaneous inflammation in severe combined immunodeficient mice that lack fuctional lymphocytes. Br. J. Dermatol., 139, 16-22 (1998).
13. Ryu, S.N., Han, S.S., Yang, J.J., Jeong, H.G., and Kang S.S., Variation of eupatilin and jaceosidin content of mugwort, Korean J. Crop Sci., 50(S), 204-207 (2005).
14. Simons, F.E.R., The antiallergic effects of antihistamines (H1-receptor antagonists). J. Allergy Clin. Immunol., 90, 705-715 (1992).
15. Schafer-Korting, M., Schmid, M.H., and Korting, H.C., Topical glucocorticoids with improved risk-benefit ratio. Drug Safety, 14, 375-385 (1996).
16. Sakuma, S., Higashi, Y., Sato, N., Sasakawa, T., Sengoku, T., Ohkubo, Y., Amaya, T., and Goto, T., Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system (Comparison with steroids). Int. Immunopharmacol, 1, 1219-26 (2001).
17. Stevens, R.L. and Austen K.F., Recent advances in the cellular and molecular biology of mast cells, Immunol, Today, 10, 381-386 (1989).
18. Suba, V., Murugesan, T., Kumaravelrajan, R., Mandal, S.C., and Saha, B.P., Antiinflammatory, analgesic and antiperoxidative efficacy of Barleria lupulina Lindl. extract. Phytother. Res., 19, 695-659 (2005).
19. Sugimoto, Y., Umakoshi, K., Nojiri, N., and Kamei, C., Effect of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur. J. Pharmacol., 351, 1-5 (1998).
20. Wuthrich, B., Epidemiology of the allergic diseases: are they really on the increase? Int. Arch. Allergy Appl. Immunol., 90 (s 1), 3-10 (1989).
21. Xiong, Q., Kadota, S., Tani, T., and Namba, T., Antioxidative effects of phenylethanoids from Cistanche deserticola. Chem. Pharm. Bull, 19, 1580-1585(1996).
22. Yang, S.H., Hong, C.Y., and Yu, C.L., Decreased serum IgE level, decreased IFN-gamma and IL-5 but increased IL-10 production, and suppressed cyclooxygenase 2 mRNA expression in patients with perennial allergic rhinitis after treatment with a new mixed formula of Chinese herbs. Int. Immunopharmacol., 1, 1173-1182 (2001).